logo
Share SHARE
FONT-SIZE Plus   Neg

Oracle Investor Files Lawsuit Against $200 Mln Settlement With GSA

An investor of enterprise software giant Oracle Corp. (ORCL) has Thursday sued its directors over damages caused to the company related to its $200 million whistle-blower settlement with the U.S. government. Jordan Weinrib filed the lawsuit earlier in the day in a Delaware Chancery court.

Weinrib revealed in the complaint filed by him that the directors, including CEO Larry Ellison, failed in their fiduciary duties to shareholders by not mitigating losses created by the settlement. He is seeking an unspecified amount in damages on behalf of Oracle shareholders.

"Rather than attempt to settle all claims at that time by the institution of appropriate corporate therapeutics and the paying of what would have been a small fine, the board insisted on digging in and litigating the matter extensively," Weinrib said in the lawsuit.

In early October, Oracle agreed to pay $199.5 million plus interest to settle a whistle-blower lawsuit that was filed for failing to meet its contractual obligations to the General Services Administration or GSA.

The settlement resolves the lawsuit filed on behalf of the U.S. government by former Oracle employee, Paul Frascella, who will receive $40 million as his share of the recovery in the case. Later, the Department of Justice took up the case by joining the whistle-blower lawsuit in 2010.

The settlement, the largest ever obtained by the GSA under the False Claims Act, relates to a contract Oracle entered into in 1998 to sell software licenses and technical support to government entities through GSA's Multiple Award Schedule program.

Oracle allegedly failed to comply knowingly with the price reduction clause of its GSA contract by not disclosing to GSA discounts Oracle gave to its commercial customers when they were higher than the discounts that Oracle had disclosed to GSA. It failed to pass those discounts on to government customers.

The U.S. government alleged that it accepted lower discounts and ultimately paid far more than it should have for Oracle products because of those alleged fraudulent dealings.

"Despite substantial evidence of wrongdoing, Oracle's board of directors did not admit that these acts had occurred, enact remedial measures and negotiate a resolution that involved a small payment. Instead, by litigating the case, Oracle drove up the ultimate settlement price, harming taxpayers and shareholders alike," Weinrib added in the lawsuit.

ORCL closed Thursday's regular trading session at $28.63, down $0.78 or 2.65% on a volume of 59.76 million shares.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
The holiday throng seeking to take a flight out to their preferred destinations at the at New York's Kennedy International Airport ahead of the Memorial Day holiday were in for a rude shock. Technology played a spoilsport, as a computer system broke down Sunday evening at a terminal, causing flight delays and cancellations that resulted in manual check-in process for thousands of holiday passeng The month of May saw the FDA greenlight 5 new drugs, including 1 new molecular entity, and surprisingly turn down 1 drug candidate, whose approval was considered a no-brainer by some experts. Lab equipment maker Thermo Fisher Scientific Inc. has agreed to acquire electron microscope maker FEI Co. for about $4.2 billion in cash, the two companies said Friday. Thermo Fisher noted that FEI's electron microscopy platform will complement its own mass spectrometry systems to accelerate advancements in structural biology.
comments powered by Disqus
Follow RTT